Category: Civica Rx

CivicaScript, a public benefit company dedicated to bringing lower-cost generic medicines to U.S. consumers, today announced the availability of its first product: abiraterone acetate 250 mg tablets. Abiraterone is used together with steroid medication (prednisone) to treat prostate cancer that has spread to other parts of the body. Starting today, CivicaScript will offer abiraterone...

Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, and CivicaScript, a statutory public benefit company dedicated to bringing lower-cost generic medicines to U.S. consumers, announced today that Navitus has joined CivicaScript as a founding member. This new partnership will enable...

Civica, Inc. (Civica Rx) announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of health care’s more pressing and enduring issues, drug shortages that disrupt patient care....

CivicaScript, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and EmsanaRx, PBC, the only pharmacy benefit manager built by employers, for employers, announced today that EmsanaRx is joining CivicaScript as a partnering member. The partnership will make CivicaScript medicines available to EmsanaRx’s self-funded employer members. “We welcome the partnership of EmsanaRx as...

Civica, Inc. announces the selection of Profil, Neuss, Germany, as its clinical trial partner to support the development of its affordable insulins. As previously announced, Civica plans to produce three insulin biosimilars – glargine, lispro and aspart – each of which will be available both in vials and prefilled pens, and sell the insulins...

Civica, Inc. announces that Ned McCoy, currently Civica’s Chief Operating Officer, will succeed Martin VanTrieste as Civica’s President and Chief Executive Officer, effective June 1. VanTrieste will remain an advisor to the Company and continue serving on Civica’s Board of Directors. As part of this transition, McCoy will also join the Civica Board of...

I am writing in support of the H.R. 7559, the Prescription Information Modernization Act, which would allow provision of prescribing information in an electronic format, instead of on paper. Civica is a non-profit generic drug company established by U.S. health systems and three philanthropic organizations to reduce chronic drug shortages and ensure a safe...

Civica Rx today announced plans to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market. The availability of affordable insulins will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly...

Congratulations, Martin VanTrieste for being named one of Modern Healthcare's "100 Most Influential in Healthcare."  Thank you for your tireless leadership, whether in the office, on Zoom, at a conference, or on the ground at our future Civica Petersburg manufacturing facility.  You inspire us to do what is in the best interest of patients...

Civica Rx  announced today that CivicaScript is the name for its operating unit dedicated to lowering the cost of select high-cost generic medicines, and that one of the nation’s largest health insurers and a leading drug manufacturer are joining the initiative. Anthem, Inc. – which operates affiliated health plans that provide health coverage to...